Lithotripsy Devices Market Size, Demand, and Future Outlook: Global Industry Trends and Forecast to 2029

Lithotripsy devices market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 6.70% in the above-mentioned forecast period.

Lithotripsy devices are basically the devices that help in the lithotripsy, which is basically the non-invasive surgery procedure which is used to treat the kidney stones which are large to pass through the urinary tract. It is generally done by passing the shock waves or sharp ultrasonic energy waves directly to the stone that is located previously with fluoroscopy or ultrasound, which further break the stone into the smaller pieces that can pass through urinary system.

Browse More About This Research Report @ https://www.databridgemarketresearch.com/reports/global-lithotripsy-devices-market

Global Lithotripsy devices market is segmented on the basis of type, modality, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

On the basis of type, the lithotripsy devices market is segmented into intracorporeal lithotripsy and extracorporeal shock wave lithotripsy (ESWL). The intracorporeal lithotripsy segment is further segmented into mechanical lithotripsy, electrohydraulic lithotripsy (EHL), laser lithotripsy and ultrasonic lithotripsy.

On the basis of modality, the lithotripsy devices market is segmented into standalone and portable.

On the basis of application, the lithotripsy devices market is segmented into kidney stone, pancreatic stones, ureteral stones and bile duct stone.

Lithotripsy devices market has also been segmented based on the end user into hospitals, ambulatory surgical centers and other.

Some of the major players operating in the lithotripsy devices market report are Richard Wolf GmbH., DirexGroup., Medispec, BD., KARL STORZ SE & Co. KG, Lumenis Be Ltd. ., Verdict Media Limited., Dornier MedTech., MedTech, Siemens, Abaxis, Hologic Inc., Bio-Rad Laboratories Inc., BD, Enzo Biochem Inc, Trivitron Healthcare, Shenzhen New Industries Biomedical Engineering Co., Ltd., Sinduri Biotec, STORZ MEDICAL AG, DirexGroup., Boston Scientific Corporation, Olympus Corporation, MEDISPEC., and Walz Elektronik GmbH among others.

Browse Trending Reports:

https://newsasdbmr.blogspot.com/2023/08/refurbished-medical-equipment-market_10.html

https://newsasdbmr.blogspot.com/2023/08/single-cell-genome-sequencing-market_10.html

https://newsasdbmr.blogspot.com/2023/08/single-use-filtration-assemblies-market_10.html

https://newsasdbmr.blogspot.com/2023/08/thoracic-surgery-devices-market.html

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

United Kingdom: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

This release was published on openPR.